利巴韦林血药浓度监测对基因1b型慢性丙型肝炎患者治疗效果的预测价值分析

doi:10.3969/j.issn.1672-5069.2018.02.035

JOURNAL OF PRACTICAL HEPATOLOGY ›› 2018, Vol. 21 ›› Issue (2): 287-288.doi: 10.3969/j.issn.1672-5069.2018.02.035

Previous Articles Next Articles

Prediction of sustained virologic response by surveillance of serum ribavirin concentration in chronic hepatitis C patients with genotype 1b infection receiving standardized antiviral therapy

Tao Guoyun, Ai Lisha, Zhang Li

Department of Infectious Diseases,General Hospital,Pingmeishenma Medical Group,Pingdingshan 467099,Henan Province

Received:2017-04-26 Online:2018-03-10 Published:2018-03-19

Abstract

Tao Guoyun, Ai Lisha, Zhang Li. Prediction of sustained virologic response by surveillance of serum ribavirin concentration in chronic hepatitis C patients with genotype 1b infection receiving standardized antiviral therapy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 287-288.

[1]	Jiang Yi, Liu Bing. Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
[2]	Wu Jing, Dong Baoji, Wu Chao. Comparison of PD-1 receptor on peripheral blood follicular helper T lymphocyte surface in chronic hepatitis C patients with low and high serum viral loads [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 192-195.
[3]	Yang Zhenjie, Li Hongtao, Wang Jian, Li Xia, Chen Yuan. Efficacy of combination of pegylated interferon-α-2a and ribavirin in treatment of patients with compensated hepatitis C cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 232-235.
[4]	Hou Chunyang, Ma Yumei, Li Fangzhi.. Clinical efficacy of peg-IFNα and ribavirin combination in treating patients with chronic hepatitis C and genotype one and six infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 53-56.
[5]	Zhao Peng, Wang Lei.. Comparison of therapeutic efficacy of pegylated interferon-α in treatment of patients with different hepatitis C viral genotype infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 57-60.
[6]	Jiao Fangzhou, Zhang Haiyue, Zhang Wenbin, et al. Efficacy of combination sofosbuvir and pegylated interferon-α in treatment of patients with chronic hepatitis C:a Meta-analysis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 220-224.
[7]	Duan Junmin, Li Susen, Liu Lizhen, et al. Comparison of efficacy of peginterferon α-2a and interferon α-2b combined with ribavirin in treatment of patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 64-67.
[8]	Zhu Chuanlong，Zhu Tiantian，Wang Kung，et al.. Serum Pygo2 levels as an indicator of liver fibrosis in patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 161-164.
[9]	Feng Xiaoxia，Nie Yuanxia，Liang Hailin.. Impact of Yiqi Jiedu Huayu compound combined with antiviral therapy on peripheral blood lymphocyte subsets and inflammatory cytokines in patients with refractory chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 674-677.
[10]	Guo Zhaoxia，Wang Yuzhen，Su Shaohui.. Prevalence of cardiovascular diseases in patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 757-761.
[11]	Zhang Guofan,Wang Fangfang,Guo Chunxia,et al.. Safety and efficacy of ascending doses interferon-α2b combined with ribavirin in treatment of patients with hepatitis-induced liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 345-346.
[12]	Zhu Guobing， Wu Linling， Tian Tian， et al.. Risk factors of thyroid?diseases in patients with chronic hepatitis C and hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 669-671.
[13]	Guan Cuiying, Anaerguli Muhamaier，Wang Yanan，et al.. Antiviral strategies of standardized regimen in patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 496-499.
[14]	zhu Yanfang，Gong Li，Fu Maoying. Combination of Zhenqi Fuzheng granule and peg-interferon alpha-2a in the treatment of patients with chronic hepatitis C [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 430-431.
[15]	Wang Yongsu, Zhang Lin, Ma Qiang, et al.. PEG-IFNα-2a plus ribavirin in treatment of patients with chronic hepatitis C:does the age influence the efficacy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(3): 294-295.

Prediction of sustained virologic response by surveillance of serum ribavirin concentration in chronic hepatitis C patients with genotype 1b infection receiving standardized antiviral therapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments